Commentary: Costs of coronary artery bypass grafting: We can do better.

J Thorac Cardiovasc Surg

Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC. Electronic address:

Published: February 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2021.04.039DOI Listing

Publication Analysis

Top Keywords

commentary costs
4
costs coronary
4
coronary artery
4
artery bypass
4
bypass grafting
4
grafting better
4
commentary
1
coronary
1
artery
1
bypass
1

Similar Publications

Eradication of commercial tobacco related disease and death.

Tob Control

December 2024

National Centre for Aboriginal and Torres Strait Islander Wellbeing Research, National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australian Capital Territory, Australia.

The eradication of the commercial tobacco industry is a crucial goal for health and well-being, particularly from a public health and health justice perspective. The term 'eradication' is applied in epidemiology to mean the process and outcome of elimination of the-commercial tobacco industry as a human-made-agent of disease and death. In this commentary, we outline why the eradication of the tobacco industry is necessary, urgent and realistic.

View Article and Find Full Text PDF

Incorporating infection prevention and control (IPC) is crucial for strengthening global surgery, particularly in low- and middle-income countries (LMICs). This review article highlights the critical role IPC plays in ensuring equitable and sustainable surgical care, aligning with the Sustainable Development Goals (SDG) 3 and 10, which aim to promote health and reduce inequalities. Surgical site infections (SSIs) and other healthcare-associated infections (HAIs) disproportionately affect LMICs, where IPC infrastructure is often underdeveloped.

View Article and Find Full Text PDF

Exploring opposing arguments in the call for randomized controlled trials to demonstrate benefit of Mohs micrographic surgery for cutaneous melanoma.

Dermatol Online J

October 2024

Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.

The call for robust randomized clinical trials (RCTs) comparing Mohs micrographic surgery (MMS) with wide local excision for treatment of melanoma has stymied the development of guidelines for MMS despite growing evidence of benefit. This commentary explores the controversy by detailing opposing arguments, reviewing the relevant evidence supporting the use of MMS for early-stage melanoma, and discussing the role that RCTs may play in development of national guidelines for surgical treatment options for melanoma. Randomized clinical trials are considered the gold standard of clinical research, but there are no such trials currently to support MMS for melanoma.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!